Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
Author(s) -
Anna M. Wang,
Subechhya Pradhan,
Jennifer M. Coughlin,
Aditi Trivedi,
Samantha DuBois,
Jeffrey L. Crawford,
Thomas W. Sedlak,
Fredrick C. Nucifora,
Gerald Nestadt,
Leslie G. Nucifora,
David J. Schretlen,
Akira Sawa,
Peter B. Barker
Publication year - 2019
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2018.3637
Subject(s) - psychosis , metabolite , medicine , population , glutamate receptor , neuropsychology , schizophrenia (object oriented programming) , psychology , psychiatry , cognition , receptor , environmental health
The use of high-field magnetic resonance spectroscopy (MRS) in multiple brain regions of a large population of human participants facilitates in vivo study of localized or diffusely altered brain metabolites in patients with first-episode psychosis (FEP) compared to healthy participants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom